Find Answers with the hATTR Compass Program:

Akcea Therapeutics and Ambry Genetics are partnering to offer no-cost, confidential genetic testing and confidential genetic counseling to patients through the hATTR Compass Program who are clinically suspected of having hereditary ATTR amyloidosis with polyneuropathy as well as individuals with a family history of hereditary ATTR amyloidosis.

Leave a Reply